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Thus far, 13 genes for autosomal dominant hearing 
loss have been localized to specific chromosomal re­
gions, but none of the genes has been cloned. Only a 
single family has been linked to each of these loci, 
with the exception of DFNA2. DFNA2 was originally 
mapped in  two extended fam ilies originating from In­
donesia and the United States. In this study we report 
linkage to DFNA2 in three additional large families 
with autosomal dominant hearing loss from Belgium  
and The Netherlands. These five DFNA2 families show  
a similar progressive sensorineural hearing loss, start­
ing in the high frequencies and also affecting the mid­
dle and low frequencies later in life. Combining the 
information from all linked fam ilies, the candidate re­
gion that is most likely to contain the DFNA2 gene was 
reduced to a 1.25-Mb region betw een markers D1S432 
andMYCLl. Different haplotypes segregating with the 
hearing loss were found in all five families, suggesting 
that different mutations are present in  the same gene. 
These results indicate that DFNA2 is most likely an 
important gene for autosomal dominant hearing loss.
© 1097 Academic Press
INTRODUCTION
Hearing loss is the most frequent condition limiting 
communication between humans. It has been esti­
mated that approximately 70 million people worldwide 
have a hearing loss of at least 55 dB (Wilson, 1985). 
Loss in hearing acuity of at least 25 dB has been re­
ported in approximately 1% of young adults and in-
1 To whom correspondence should be addressed. Telephone; 323- 
8202570. Fax: 323-8202566.
creases markedly with age to approximately 10% at 
age 60 and 50% at age 75 or older (Morton, 1991). Pro­
gressive hearing loss of the elderly (presbycusis) is 
probably due to a multifactorial interaction of genetic 
and environmental factors. In some cases, progressive 
postlingual hearing loss is monogenic, and many au­
tosomal dominant families with this type of hearing 
loss have been described (Cohen and Gorlin, 1995). By 
identifying genes responsible for monogenic hearing 
loss, more insight may be gained into the molecular 
process of hearing and the pathology of hearing loss, 
which may help in understanding the complex multi­
factorial process of presbycusis.
Initially, localization of genes responsible for nonsyn- 
dromic hearing loss has been very slow. To date, how­
ever, 26 genes have been localized to specific autosomal 
regions by linkage analysis. These genes have been 
classified in two categories: DFNA for autosomal domi­
nant hearing loss and DFNB for autosomal recessive 
hearing loss. Nearly all DFNA families generally have 
progressive hearing loss that is often mild at a younger 
age, while most of the DFNB families have a profound 
congenital deafness. A list of all published loci, includ­
ing detailed genetic and clinical information, can be 
found on-line in the Hereditary Hearing Loss Home­
page (http://www-dnalab.uia. ac.be/dnalab/hhh/).
Recently, we mapped a gene for autosomal dominant 
sensorineural hearing loss starting in the high frequen­
cies (DFNA2) to chromosome 1 in an extended family 
originating from Indonesia, and we found that the 
same gene is responsible for hearing loss in a family 
from the United States (Coucke et al., 1994). Here we 
report three additional large families from Belgium 
and The Netherlands with a similar type of progressive 
hearing loss, linked to DFNA2. Combining the informa-
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tion from all five linked families, we were able to reduce 
the region that most likely contains the DFNA2 gene 
to a 1.25-Mb region between genetic markers D1S432 
and MYCL1.
telomere
MATERIALS AND METHODS
Clinical diagnosis. Otologic examination and pure tone audiome­
try with air and bone conduction were performed on every family 
member who participated in this study, and blood samples were 
taken for DNA extraction. The audiometric curves of all family mem­
bers were compared with age- and sex-dependent percentile curves 
(International Organization for Standardization, 1984). Family 
members were considered affected if they had a sensorineural hear­
ing loss with an audiometric curve below the 95th percentile (P95) 
of the reference curves for most frequencies for both ears. Family 
members were considered unaffected if hearing thresholds at most 
frequencies were better than 20-dB hearing level or above the 50th 
percentile. Normal-hearing individuals below the age of 35 for the 
Belgian family, below 40 for Dutch family 1, and below 25 for Dutch 
family 2 were given an unknown disease status in the linkage analy­
sis. Persons with an atypical or doubtful audiogram, or with a history 
of environmental factors that could be implicated in their hearing 
loss, were also given an unknown disease status. In a few cases, the 
family history of married-in individuals revealed a possible heredi­
tary hearing loss. These individuals and their children were also 
given an unknown affection status.
Belgian family. A family pedigree consisting of approximately 
150 family members over 4 generations was constructed. Audiometry 
was performed and blood samples were obtained from 65 family 
members. Twenty-seven family members were diagnosed as affected. 
In most affected family members between 10 and 30 years of age, 
hearing was impaired only at frequencies above 1000 Hz. Above the 
age of 30, a loss below 1000 Hz generally became apparent, although 
this was in some cases not below the P95 of the reference curves. 
The average progression rate of the hearing loss in this family was 
much higher above 1000 Hz (between 2 and 5 dB per year) than 
below 1000 Hz (between 0.2 and 0.5 dB per year).
Dutch family 1. A pedigree comprising more than 250 family 
members in 6 generations was constructed. Eighty-eight family 
members were tested audiometrically, and blood samples were ob­
tained from all of them. Forty-one family members were diagnosed 
as affected. In all affected persons, a hearing loss that was most 
pronounced in the high frequencies and that showed a progress of 
approximately 1 dB per year could be demonstrated.
Dutch family 2 . A pedigree of over 400 family members in 6 gen­
erations was reconstructed. Eighty-four of these were tested audio­
metrically, and blood samples were obtained from them. Twenty- 
four of them were diagnosed as affected. In this family a progressive 
hearing loss starting in the high frequencies, which was very similar 
to Dutch family 1, was found.
Microsatellite analysis. Microsatellites were typed according to 
standard procedures. Allele sizes were determined by comparison 
with the known genotype of CEPH individual 134702 (Dib et a l ,  
1996). D1S432 is a microsatellite located 5 cM centromeric from 
D1S255 and 2 cM telomeric from D1S193 on the Gen^thon genetic 
map (Dib et aL, 1996). On the physical map of Hellsten et al. (1995), 
the tetranucleotide repeat marker MYCL1 is located close to DIS 193, 
on the telomeric side. Recombinants in several families confirmed 
the order D1S255-D1S432-MYCL1-D1S193 (data not shown). As 
D1S432 and MYCL1 are not accurately positioned on the same ge­
netic map, the exact genetic distance between them remains un­
known. However, DIS432 and MYCL1 are separated by less than 
1.25 Mb from each other, as we identified two CEPH YACS (901_a_l 
and 935_e_l) with lengths of 1.25 and 1.8 Mb, respectively, that 
contain both markers. Detailed information for the genetic markers 
used in this study can be found in the Genome Database (Fasman 
Gt al,, 1996). A map showing the relative localization of these four 
genetic markers flanking DFNA2 is shown in Fig. 1.
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FIG. 1. Left; Map of genetic markers flanking DFNA2. The 
DFNA2 candidate region between D1S432 and MYCL1, as indicated 
by the key recombinations, is indicated in bold. Both markers are 
located at a distance less than 1.25 Mb from each other. Right: 
Schematic representation of the chromosomes with key recombina­
tions between DFNA2 and closely linked markers. Informative al­
leles are represented by circles: the circles are filled in the region 
containing the DFNA2 gene and open in the regions from which 
DFNA2 is excluded based on this key recombinant. Arrows indicate 
the position of DFNA2. The number above the chromosomes indi­
cates how often this type of recombination was observed.
Linkage parameters. Linkage calculations were performed using 
the Linkage program, Version 5.1 (Lathrop and Lalouel, 1984), and 
the Fastlink programs (Cottingham et aL, 1993). The frequency of 
hearing loss due to mutations in DFNA2 was set at 1/10,000. Pene­
trance was set at 98%, and the chance that family members without 
a mutation in DFNA2 showed hearing loss was set at 2%, to allow 
for possible phenocopies. Recombination frequencies were assumed 
to be equal for males and females. For each marker the number of 
alleles in the lod score calculations was set at the observed number 
of alleles in the pedigree (A0, and allele frequencies were set equal 
at 1 IN, Changes in the allele frequencies resulted only in minor 
alterations of the two-point lod scores and did not alter the conclu­
sions of the study.
RESULTS
Linkage Analysis
Positive linkage to the short arm of chromosome 1 
had been demonstrated previously in an Indonesian 
and an American family with autosomal dominant non- 
syndromic progressive hearing loss (DFNA2) with
markers D1S201, D1S255, D1S193, and D1S211 
(Coucke et al., 1994).
In this study we identified three additional families 
with a similar type of hearing loss linked to DFNA2 and 
analyzed two new markers from the DFNA2 region, 
D1S432 and MYCL1. The localization of these markers 
relative to the markers used in the original study is 
given in Fig. 1. Two-point lod scores for MYCL1 and 
D1S432 in all five DFNA2 families are given in Table 
1. Positive lod scores over +3.0 were obtained for all
72 VAN CAMP ET AL.
TABLE 1
Two-Point Lod Scores for Linkage between Hearing Loss and Micro satellite Markers
on Chromosome Ip in Five Different Families
Lod score at 6 =
Locus Family 0.00 0.01 0.05 0.10 0.20 0.30 0.40
D1S432 Indonesian 10,92 10.72 9.91 8.85 6.61 4.24 1.89
American 3.53 3.61 3.59 3.33 2.55 1.62 0.65
Belgian 6,35 6.23 5.73 5.08 3.71 2.29 0.95
Dutch 1 0.44 3,27 4.89 5.14 4.39 3.08 1.55
Dutch 2 4.10 4.17 4.13 3,85 3.03 2.00 0.86
Total 25.34 28.00 28.25 26.25 20.29 13.23 5.90
MYCLl Indonesian 6.88 6.90 6.62 6.03 4.53 2.87 1.25
American 7.16 7.03 6.52 5.86 4.44 2.91 1.33
Belgian 4.58 4.63 4,50 4.09 3.02 1.82 0.76
Dutch 1 8.72 8.85 8.70 8.05 6.28 4.26 2,12
Dutch 2 6.69 6.73 6.54 6.06 4.78 3.23 1.47
Total 34.03 34.14 32.88 30.09 23.05 15.09 6.93
families, giving conclusive evidence of linkage in each recombinants indicate that the DFNA2 gene most
of the families. likely lies between D1S432 and MYCL1 (Fig. 1),
Key Recombinants Phenocopies
In our previous study (Coucke et aL, 1994), a 6-cM Surprisingly, one individual from the Belgian family 
candidate region for DFNA2 was defined between and two individuals from Dutch family 1 diagnosed 
markers D1S255 and D1S211. This candidate region as affected by audiometry did not inherit the disease 
was delineated by a single key recombinations in the haplotype from their affected parent but inherited the 
American family with D1S255 on its telomeric side and normal haplotype. A double recombination between 
by a single key recombinant in the Indonesian family DFNA2 and the two informative flanking markers 
with D1S211 on its centromeric side. D1S193 located D1S432 and MYCL1 is unlikely as these two markers 
1 cM distal to D1S211 was uninformative in the Indo- are very closely linked. Therefore, the hearing loss in 
nesian recombinant. To reduce this candidate region, these three individuals most likely represents a pheno- 
the new markers D1S432 and MYCL1 were analyzed copy. Their medical history did not disclose any envi- 
in the key recombinants from the Indonesian and ronmental factor that might explain their hearing loss, 
American families. The Indonesian key recombinant and reevaluation of the audiograms revealed no misdi­
mt h marker D1S211 also recombines with MYCL1, lo- agnosis. Most likely, another gene or nongenetic factors 
calizing DFNA2 telomeric of MYCLl. Analysis of the are responsible for the hearing loss in these three pa-
American key recombinant places DFNA2 centromeric tients. In the other three families, no phenocopies were
of D1S432. Both key recombinants reduce the DFNA2 found, 
candidate region to the interval between D1S432 and
MYCLl, with a single recombinant on both sides. Haplotype Comparison
To confirm this candidate region, the most likely dis­
ease haplotype for D1S255, D1S432, MYCLl, and We investigated the possibility that some of the five 
D IS 193 was constructed in the three new DFNA2 fami- DFNA2 families are related to each other by comparing 
lies. This revealed five recombinations in the region the disease haplotypes of the five DFNA2 families. Five 
between D1S255 and D1S432, localizing DFNA2 cen- different linked haplotypes were found. For the two 
tromeric of D1S255. Four recombinations in the region closest flanking markers D1S432 and MYCLl, respec- 
between D1S432 and MYCLl in Dutch family members tively four and five different linked alleles are present 
(three affected individuals in family 1 and one unaf- in the five families. It has been calculated that a region 
fected individual in family 2) localize DFNA2 centro- of 1 cM remains identical by descent between two de- 
meric of D1S432, confirming the recombinant in the scendants of a common ancestor for more than 15 gen- 
American family. Three recombinations in the region erations (meiotic count of 30) with a probability of 95% 
between D1S193 and MYCLl localize DFNA2 te- (te Meerman et aL, 1994). Therefore, it is unlikely that 
lomeric of D1S193. The Indonesian recombinant lo- any pair of the five DFNA2 families is related up to 15 
calizing DFNA2 telomeric to MYCLl was not confirmed generations ago, with the exception of the American- 
by other recombinants in the three new families. No Dutch 2 pair, who have the same allele for D1S432. 
key recombinants were present in the Belgian family. However, it is impossible to know whether the allele 
Combining all five DFNA2 families, a total of six key for D1S432 in these two families is identical by descent
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or just by chance. Overall, it is likely that most of the 
five DFNA2 families carry mutations in the DFNA2 
gene that have arisen on separate occasions.
DISCUSSION
In this study we describe very conclusive linkage of 
three new families with nonsyndromic progressive 
hearing loss starting in the high frequencies to the 
DPNA2 locus on chromosome lp. These three families 
originate from Belgium and The Netherlands, and to­
gether with the Indonesian and American family that 
we reported earlier, they bring the total of families 
linked to DFNA2 to five.
Six key recombinants in these five families reduce 
the DFNA2 candidate region to a small interval be­
tween D1S432 and MYCL1. However, it must be kept 
in mind that only a single proximal recombinant with 
MYCL1 was found up to now. The possibility that this 
is not a true recombinational event but a phenocopy 
cannot be excluded, as this patient has no affected chil­
dren and phenocopies for this type of deafness are not 
uncommon. Therefore, a more conservative candidate 
region for DFNA2, based on at least two recombinants 
on each side of the DFNA2 gene, would be the 3-cM 
interval between D1S432 and D1S193. Highly poly­
morphic markers are present on both sides of this inter­
val, providing a very reliable predictive and diagnostic 
DNA test that is now available for families in which 
hearing loss is linked to DFNA2. Early presymptomatic 
diagnosis based upon DNA analysis can be important 
in career planning and school choice. Apart from its 
predictive value in young individuals at risk to develop 
hearing loss, the DNA test also has a confirmatory 
value in cases with an uncertain audiometric diagnosis. 
In addition, the DNA test can uncover incorrect audio­
metric diagnoses, as illustrated by the presence of three 
phenocopies in this study.
The presence of three phenocopies in these five 
DFNA2 families is not unexpected for two reasons. 
First, a total of 138 patients from these five families 
were included in our study. Second, hearing impair­
ment of the high tones is very frequent, especially in 
the older population. To differentiate between hearing 
loss caused by DFNA2 and age-related hearing loss 
caused by other factors, .we have used age- and sex- 
dependent reference curves for hearing thresholds. 
Family members were only considered affected if they 
had hearing thresholds below the P95 of the curves for 
several frequencies. However, as 5% of the population 
has a hearing threshold below the P95 threshold, 
applying only this criterium could lead to up to 5% 
phenocopies in the clinical diagnosis. Therefore, anam­
nestic data, such as noise exposure, and the careful 
comparison of the audiometric curves for all family 
members were also used to reduce the number of possi­
ble phenocopies. In case of doubt, family members were 
given an unknown affection status. However, even by 
applying these strict criteria, phenocopies can never be
eliminated, as some of these phenocopies are phenotyp- 
ically indistinguishable from hearing loss caused by 
mutations in the DFNA2 gene.
As the DFNA2 flanking markers, D1S432 and 
MYCL1, colocalize to the same YAC of 1.25 Mb, this 
region is amenable to positional cloning of the DFNA2 
gene. Mycll, the mouse homologue of human MYCL1, 
is located on mouse chromosome 4, and a large region 
surrounding Mycll has syntenic homology to human 
chromosome lp. Therefore, the human homologues of 
genes located close to Mycll in the mouse, such as gap 
junction gene Gja5, colony-stimulating factor granulo­
cyte receptor Csfr, and the collagen gene Col8a2 (Cope­
land et al.} 1993), may be a source of candidate genes 
for DFNA2. Although several mouse mutations that 
affect hearing are located on mouse chromosome 4, 
none of them is located in the vicinity of Mycll (Nadeau
et aL, 1991).
The five families linked to DFNA2 have a similar 
type of progressive hearing loss, starting in the high 
tones and progressing1 with age to include middle and 
lower frequencies. Nevertheless, statistical analysis of 
the audiograms shows significant differences in the 
progression rate of the hearing loss between some of 
the families from Western Europe (data not shown). 
This variability suggests allelic heterogeneity, the vari­
ous families having a different mutation in DFNA2, 
which is also confirmed by the finding of a different 
haplotype segregating with hearing loss in each of the 
five linked families. Many independent recombinations 
would be necessary to change the haplotypes from all 
these families into a single haplotype from a hypotheti­
cal ancestral founder chromosome. The occurrence of 
all these hypothetical recombinations, including a 
number of recombinations in the 1.25-Mb region be­
tween D1S432 and MYCL1, would require a large num­
ber of meioses. Although a common ancestor for all 
families can never be formally ruled out, it is more 
likely that different mutations have occurred in the 
same gene. This suggests that DFNA2 is an important 
gene for autosomal dominant hearing loss.
We have tested a total of 21 large families with au­
tosomal dominant hearing loss for linkage with DFNA2 
(data not shown), and 5 of them were linked, strongly 
suggesting that the DFNA2 gene is frequently involved 
in hereditary progressive hearing loss. The type of 
hearing loss in the families linked to DFNA2 is similar 
to that of presbycusis in view of its sensorineural origin 
and progressive evolution first affecting the high tones. 
Therefore, DFNA2 might be involved in the pathogene­
sis of age-related hearing loss, and the DFNA2 families 
may serve as a model for studying mechanisms leading 
to presbycusis.
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